Abbrea Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.24M | Sell |
11,616
-140
| -1% | -$14.9K | 0.16% | 104 |
|
|
2024
Q1 | $1.18M | Hold |
11,756
| – | – | 0.16% | 114 |
|
|
2023
Q4 | $1.19M | Hold |
11,756
| – | – | 0.17% | 106 |
|
|
2023
Q3 | $1.2M | Hold |
11,756
| – | – | 0.19% | 100 |
|
|
2023
Q2 | $1.19M | Hold |
11,756
| – | – | 0.18% | 101 |
|
|
2023
Q1 | $1.08M | Hold |
11,756
| – | – | 0.18% | 107 |
|
|
2022
Q4 | $1.07M | Hold |
11,756
| – | – | 0.19% | 107 |
|
|
2022
Q3 | $894K | Sell |
11,756
-75
| -0.6% | -$5.7K | 0.17% | 111 |
|
|
2022
Q2 | $1M | Hold |
11,831
| – | – | 0.17% | 108 |
|
|
2022
Q1 | $1.04M | Hold |
11,831
| – | – | 0.15% | 115 |
|
|
2021
Q4 | $1.04M | Hold |
11,831
| – | – | 0.14% | 122 |
|
|
2021
Q3 | $968K | Hold |
11,831
| – | – | 0.14% | 113 |
|
|
2021
Q2 | $1.08M | Hold |
11,831
| – | – | 0.16% | 105 |
|
|
2021
Q1 | $1.01M | Hold |
11,831
| – | – | 0.17% | 100 |
|
|
2020
Q4 | $1.12M | Buy |
11,831
+331
| +3% | +$31.3K | 0.2% | 91 |
|
|
2020
Q3 | $1M | Sell |
11,500
-215
| -2% | -$18.7K | 0.21% | 90 |
|
|
2020
Q2 | $1.02M | Hold |
11,715
| – | – | 0.23% | 87 |
|
|
2020
Q1 | $966K | Hold |
11,715
| – | – | 0.26% | 87 |
|
|
2019
Q4 | $1.11M | Hold |
11,715
| – | – | 0.24% | 91 |
|
|
2019
Q3 | $1.02M | Hold |
11,715
| – | – | 0.24% | 91 |
|
|
2019
Q2 | $1.07M | Buy |
+11,715
| New | +$1.07M | 0.26% | 88 |
|